Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Medtronic
Boehringer Ingelheim
Chinese Patent Office
Chubb
McKinsey
Merck
Cerilliant
Fish and Richardson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020071

« Back to Dashboard

NDA 020071 describes DESOGEN, which is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. Additional details are available on the DESOGEN profile page.

The generic ingredient in DESOGEN is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 020071
Tradename:DESOGEN
Applicant:Organon Usa Inc
Ingredient:desogestrel; ethinyl estradiol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020071
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071 NDA Organon USA Inc. 0052-0261 N 0052-0261-08
DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-28 020071 NDA Organon USA Inc. 0052-0261 N 0052-0261-08

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.15MG;0.03MG
Approval Date:Dec 10, 1992TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.15MG;0.03MG
Approval Date:Dec 10, 1992TE:ABRLD:No

Expired US Patents for NDA 020071

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071-001 Dec 10, 1992 ➤ Sign Up ➤ Sign Up
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-28 020071-002 Dec 10, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Army
QuintilesIMS
Citi
AstraZeneca
Moodys
McKinsey
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot